Cargando…

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma

Detalles Bibliográficos
Autores principales:	Ma, Yu-Ting, Li, Yan, Yan, Li, Hua, Fang, Wang, Dong-Guan, Xu, Guo-Ying, Yang, Hong-Lan, Xue, Ying-Jie, Qin, Ye-Jun, Sha, Dan, Ning, Hao, Zhao, Miao-Qing, Yao, Zhi-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924308/ https://www.ncbi.nlm.nih.gov/pubmed/36794259 http://dx.doi.org/10.3389/pore.2023.1610989

Ejemplares similares

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
por: Zhang, Qi, et al.
Publicado: (2023)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers
por: Liu, Fangcen, et al.
Publicado: (2023)

PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays
por: Evans, Harriet, et al.
Publicado: (2022)

Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule Nocardia rubra Cell-Wall Skeleton
por: Wu, Jie, et al.
Publicado: (2022)

Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
por: Wu, Hui, et al.
Publicado: (2023)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
por: Du, YunYi, et al.
Publicado: (2022)

Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
por: Oliveira, André F., et al.
Publicado: (2019)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm
por: Ozer, Muhammet, et al.
Publicado: (2023)

Case report: Urothelial carcinoma of the renal pelvis with trophoblastic differentiation: A rare case report and review of literature
por: Wang, Zhuo, et al.
Publicado: (2023)

Corrigendum: The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2022)

Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis
por: Choi, Jina, et al.
Publicado: (2023)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
por: Hu, Boyi, et al.
Publicado: (2022)

Potential predictors of immunotherapy in small cell lung cancer
por: Skopelidou, Valeria, et al.
Publicado: (2023)

Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
por: Zhang, Xuan, et al.
Publicado: (2022)

A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer
por: Xie, Yan, et al.
Publicado: (2022)

Corrigendum: Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer
por: Diao, Bowen, et al.
Publicado: (2022)

Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas
por: Kelany, Mohamed, et al.
Publicado: (2021)

Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022)

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
por: Yan, Wen-Yue, et al.
Publicado: (2016)

Comparison of Multi-Gene Testing Data Between Fresh and Formalin-Fixed Specimens From Core Needle Biopsy in Patients With NSCLC
por: Yao, Zhi-Gang, et al.
Publicado: (2021)

Corrigendum: Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan
por: Lu, Meng-Yao, et al.
Publicado: (2022)

Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters
por: Hashmi, Atif A, et al.
Publicado: (2023)

Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022)

Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
por: Boniface, Christopher T., et al.
Publicado: (2023)

Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy
por: Chida, Keigo, et al.
Publicado: (2022)

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer
por: Rubovszky, Gábor, et al.
Publicado: (2023)

Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
por: Wang, Zhenghang, et al.
Publicado: (2022)

Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
por: Li, Jin-Jin, et al.
Publicado: (2022)

Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy
por: Pfaendler, Krista S, et al.
Publicado: (2022)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation
por: Zhang, Lei, et al.
Publicado: (2023)

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
por: Varnier, Romain, et al.
Publicado: (2021)

Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
por: Mulet-Margalef, Núria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_891q75339lm9hsa50gosrifu5d